The ACGT project is supported by major European partners from eleven European countries and is focused on defined objectives to reach one goal: to fight cancer. This project is targeting currently two main cancer diseases, namely breast cancer (BRCA) and paediatric nephroblastoma (PN), currently run by three clinical trials.
The ACGT developed tool, the Biomedical GRID infrastructure, offers supporting seamless mediation services for sharing clinical and genomic expertise, data and data-processing. It provides also to researchers and patricians optimal means and resources to fight cancer.
ACGT parallel purpose is also to develop new ontologies for cross-referencing terms in their biological contexts, as well as the use of other disciplines in bioinformatics and medical informatics including medical imaging.
Then, by introducing innovative approach for combined clinico-genomic trials, the rapid identification of individualised molecular profiles correlated with sensitivity or resistance to therapy will be possible and make a great step in the whole medicine research.
